Ibuprofen Market Forecast, Trend Analysis & Competition Tracking - Global Industry Insights 2015 to 2031

Ibuprofen Market: Overview

Ibuprofen is a medication that comes under the Nonsteroidal Anti-Inflammatory Drug (NSAID) category. It is a derivative of propionic acid. It is used for the treatment of common symptoms such as pain, fever, and inflammation. Ibuprofen has a powdery white appearance and is also available in capsules, tablets, or powder.  It is indicated for analgesic and anti-inflammatory effects in the treatment of rheumatoid arthritis, gouty arthritis, osteoarthritis, ankylosing spondylitis, and other non-rheumatoid (seronegative) arthropathies.

Global Ibuprofen Market Revenue Outlook:

The global ibuprofen market is valued at US$ 7,215.5 Mn in 2020 and is projected to register а САGR of 2.4% by 2031.

Nonetheless, various industry players in the global Ibuprofen market are now increasing their focus towards the establishment of successful collaborations, acquisitions, and joint venture activities as a means to enhance their respective customer bases. In doing so, these players are also increasing their supply capabilities to meet customer requirements on a local and global scale. This factor, paired with promising industrialization prospects in developing economies of the Asia-Pacific region, such as China, India, Taiwan, Indonesia, etc., are expected to create massive business opportunities for key players over the forecast period.

The increasing prevalence of chronic diseases is boosting the growth of the global Ibuprofen market

The increasing incidence and prevalence of chronic diseases such as cardiovascular disease, cancer, arthritis, among others, are continuously increasing the demand and consumption of ibuprofen drugs. This factor is expected to fuel the projected revenue growth of the global Ibuprofen market in the years to come.

• According to World Health Organization, Worldwide, the annual Rheumatoid Arthritis (RA) incidence is approximately 3 cases per 10,000 population. The prevalence rate is approximately 1%, increasing with age with a range between the ages of 35 and 50 years.

Common Brand names available for Ibuprofen include:

• Advil
• Pediatric Advil
• Advil/Motrin
• Advil Migraine
• Medipren
• Motrin
• Nuprin
• Caldolor
• Duexis
• IBU-Tab
• Neoprofen
• Others

Doses of Ibuprofen in Adult & Children

To learn more about this report, request for Sample Report

Acceptable dosage forms and strengths are shown in the table below.

To learn more about this report, request for Sample Report

Short and long term side effects of ibuprofen drug are expected to hamper the demand and revenue growth

The most common type of adverse reaction occurring with Ibuprofen is the gastrointestinal tract (GIT). In clinical trials, the percentage of patients reporting one or more gastrointestinal complaints ranged from 4% to 16%. Adverse effects include nausea, dyspepsia, diarrhea, constipation, headache, dizziness, rashes, gastrointestinal ulceration/bleeding, salt and fluid retention, and high blood pressure. Long-term side effects include heart failure, esophageal ulceration, high blood potassium levels, kidney impairment, liver damage, confusion, and bronchospasm. This factor is expected to hamper the revenue growth for this target market.

Some recent trends expected to have a positive impact on the growth of the market

The high availability of Ibuprofen as an OTC drug has led to the wide distribution of drugs in several parts of the world, including remote areas. Moreover, the drug does not require a prescription from physicians. It can be taken for acute pain relief by all ages, thereby boosting the increase in the demand for Ibuprofen, leading to the subsequent spike in the projected revenues of this global industry over the next ten years.

The availability of OTC drugs, including Ibuprofen on online portals, has gained significant traction for the past couple of years. The emergence of pharmacy portals such as drugs.com, dokteronline.com, mCHEMIST.com, Medidart.com, etc., and prescription and non-prescription drugs on these websites are likely to continue to provide a substantial boost to the global ibuprofen market.

Some notable developments in increasing production capacity for Ibuprofen

• In August 2018, SI Group, a leading global developer and manufacturer of performance additives and intermediates, announced plans to expand ibuprofen capacity in its Orangeburg, South Carolina facility in the US. The expansion will increase production by 25% and is expected to commercialize by 2020.
• In June 2017, BASF planned to build a new chemical plant to expand ibuprofen capacity in Ludwigshafen, Germany, which is expected to come on-stream by 2021; this is expected to increase the supply of Ibuprofen in the market, thereby driving the overall growth of the global ibuprofen market further.

Regional Analysis

Asia-Pacific is expected to have a significant market share, among others

The Asia Pacific is expected to hold a significant value share in the global ibuprofen market, owing to the increased geriatric population and inflammatory diseases. In 2021, the market in APAC is estimated to be valued at US$ XX Mn and register a market share of 28.4%. The market is expected to reach a value of US$ XX Mn and register a CAGR of 2.7% between 2015 and 2031.

The North America and Europe market is expected to follow the same trend owing to changes in lifestyles and increased spending on healthcare activities across the regions. The Ibuprofen market in North America is estimated to account for a revenue share of XX% in 2021 and is expected to register a CAGR of XX% during the forecast period.

Competitive Landscape

Some of the major leading players operating in the ibuprofen market are listed below:

• SI Group, Inc.
• BASF SE
• Perrigo Company plc
• Mallinckrodt plc
• Strides Pharma Science Limited
• IOL Chemicals and Pharmaceuticals Limited
• Hubei Biocause Pharmaceutical Co., Ltd.
• Shandong Xinhua Pharmaceutical Co., Ltd.
• Other Key Industry Players

Report Scope

• Forecast Period: 2022-2031
• Actual Year: 2021
• Historical Data Available for: 2015-2020

Key Regions Covered

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Segments Covered

Ibuprofen Market, By Type

• USP-United States Pharmacopeia (USP) Reference Standard
• EP-European Pharmacopoeia (EP) Reference Standard

Ibuprofen Market, By Form

• Tablet
• Capsule
• Suspension

Ibuprofen Market, By Sales Channel

• Retail Pharmacies
• Online Pharmacies
• Hypermarket & Drug Stores

To learn more about this report, request for Sample Report